Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mario Cazzola

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Phenomena

Forced Expiratory Volume

Procedures

Concepts & Ideas

Anatomy

Hematopoietic Stem Cells

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
57
Matera, Maria Gabriella
47
Bergamaschi, Gaetano
29
Rosti, Vittorio
27
Passamonti, Francesco
26
Lazzarino, Mario
26
D'Amato, Gennaro
25
Malcovati, Luca
24
Rossi, Francesca
23
Centanni, Stefano
22
Pascutto, Cristiana
21
Invernizzi, Rosangela
20
Santus, Pierachille
19
Rumi, Elisa
19
Ponchio, Luisa
18
Della Porta, Matteo

Sign-in to see all Coauthors

Publications

TOP 3
Cazzola Mario; Rogliani Paola; Curradi Giacomo; Segreti Andrea; Ciaprini Chiara; Pezzuto Gabriella; Saltini Cesare
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.
Matera Maria Gabriella; Calzetta Luigino; Parascandolo Vincenzo; Curradi Giacomo; Rogliani Paola; Cazzola Mario
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi.
Comandini Alessia; Rogliani Paola; Nunziata Alfredo; Cazzola Mario; Curradi Giacomo; Saltini Cesare
Biomarkers of lung damage associated with tobacco smoke in induced sputum.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mario Cazzola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cazzola Mario; Rogliani Paola; Curradi Giacomo; Segreti Andrea; Ciaprini Chiara; Pezzuto Gabriella; Saltini Cesare
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.
Pulmonary pharmacology & therapeutics 2009;22(6):522-5.
2009: Matera Maria Gabriella; Calzetta Luigino; Parascandolo Vincenzo; Curradi Giacomo; Rogliani Paola; Cazzola Mario
Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi.
Pulmonary pharmacology & therapeutics 2009;22(6):478-82.
2009: Comandini Alessia; Rogliani Paola; Nunziata Alfredo; Cazzola Mario; Curradi Giacomo; Saltini Cesare
Biomarkers of lung damage associated with tobacco smoke in induced sputum.
Respiratory medicine 2009;103(11):1592-613.
2009: Cazzola Mario; Tashkin Donald P
Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function.
COPD 2009;6(5):404-15.
2009: Malcovati Luca; Della Porta Matteo G; Pietra Daniela; Boveri Emanuela; Pellagatti Andrea; Gallì Anna; Travaglino Erica; Brisci Angela; Rumi Elisa; Passamonti Francesco; Invernizzi Rosangela; Cremonesi Laura; Boultwood Jacqueline; Wainscoat James S; Hellström-Lindberg Eva; Cazzola Mario
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Blood 2009;114(17):3538-45.
2009: Passamonti Francesco; Rumi Elisa; Arcaini Luca; Elena Chiara; Castagnola Carlo; Zappasodi Patrizia; Bernasconi Paolo; Pietra Daniela; Pascutto Cristiana; Cazzola Mario; Lazzarino Mario
Blast phase of essential thrombocythemia: A single center study.
American journal of hematology 2009;84(10):641-4.
2009: Pellagatti Andrea; Marafioti Teresa; Paterson Jennifer C; Malcovati Luca; Della Porta Matteo G; Jädersten Martin; Pushkaran Beena; George Tracy I; Arber Daniel A; Killick Sally; Giagounidis Aristoteles; Hellström-Lindberg Eva; Cazzola Mario; Wainscoat James S; Boultwood Jacqueline
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
British journal of haematology 2009;146(1):86-90.
2009: Cazzola Mario; Santus Pierachille; D'Adda Alice; Pizzolato Silvia; Di Marco Fabiano; Centanni Stefano
Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
Pulmonary pharmacology & therapeutics 2009;22(3):177-82.
2009: Cazzola Mario; Noschese Paolo; Di Perna Felice
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.
Therapeutic advances in respiratory disease 2009;3(2):59-63.
2009: Cazzola Mario; Bettoncelli Germano; Sessa Emiliano; Cricelli Claudio
Primary care of the patient with chronic obstructive pulmonary disease in Italy.
Respiratory medicine 2009;103(4):582-8.
2009: Della Porta Matteo Giovanni; Malcovati Luca; Boveri Emanuela; Travaglino Erica; Pietra Daniela; Pascutto Cristiana; Passamonti Francesco; Invernizzi Rosangela; Castello Alessandro; Magrini Umberto; Lazzarino Mario; Cazzola Mario
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):754-62.
2009: Rumi E; Passamonti F; Pagano L; Ammirabile M; Arcaini L; Elena C; Flagiello A; Tedesco R; Vercellati C; Marcello A P; Pietra D; Moratti R; Cazzola M; Lazzarino M
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.
Journal of internal medicine 2009;265(2):266-74.
2008: Cazzola Mario; Matera Maria Gabriella
Treatment of asthma during pregnancy: more solid evidence needed.
Thorax 2008;63(11):944-5.
2008: Mufti Ghulam J; Bennett John M; Goasguen Jean; Bain Barbara J; Baumann Irith; Brunning Richard; Cazzola Mario; Fenaux Pierre; Germing Ulrich; Hellström-Lindberg Eva; Jinnai Itsuro; Manabe Atsushi; Matsuda Akira; Niemeyer Charlotte M; Sanz Guillermo; Tomonaga Masao; Vallespi Teresa; Yoshimi Ayami;
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Haematologica 2008;93(11):1712-7.
2008: Cazzola Mario; Matera Maria Gabriella
Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
American journal of respiratory and critical care medicine 2008;178(7):661-2.
2008: Cazzola Mario; Malcovati Luca
Prognostic relevance of anemia in myelodysplastic syndromes.
American journal of hematology 2008;83(10):761-2.
2008: Cazzola Mario; Biscione Gian Luca; Pasqua Franco; Crigna Girolmina; Appodia Massimiliano; Cardaci Vittorio; Ferri Luigi
Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD.
Respiratory medicine 2008;102(10):1425-30.
2008: Melis Maria Antonietta; Cau Milena; Congiu Rita; Sole Gabriella; Barella Susanna; Cao Antonio; Westerman Mark; Cazzola Mario; Galanello Renzo
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
Haematologica 2008;93(10):1473-9.
2008: Rumi Elisa; Passamonti Francesco; Picone Cristina; Della Porta Matteo Giovanni; Pascutto Cristiana; Cazzola Mario; Lazzarino Mario
Disease anticipation in familial myeloproliferative neoplasms.
Blood 2008;112(6):2587-8; author reply 2588-9.
2008: Cazzola Mario; Matera Maria Gabriella
To add, or not to add an inhaled corticosteroid in moderate COPD: that is the question.
Chest 2008;134(2):223-5.
2008: Pelaia Girolamo; Renda Teresa; Gallelli Luca; Vatrella Alessandro; Busceti Maria Teresa; Agati Sergio; Caputi Mario; Cazzola Mario; Maselli Rosario; Marsico Serafino A
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma.
Respiratory medicine 2008;102(8):1173-81.
2008: Braido Fulvio; Bellotti Michele; De Maria Andrea; Cazzola Mario; Canonica Giorgio Walter
The role of Pneumococcal vaccine.
Pulmonary pharmacology & therapeutics 2008;21(4):608-15.
2008: Matera M G; Calzetta L; Sanduzzi A; Page C P; Cazzola M
Effects of neuraminidase on equine isolated bronchi.
Pulmonary pharmacology & therapeutics 2008;21(4):624-9.
2008: Cazzola Mario
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
Haematologica 2008;93(7):967-72.
2008: Jädersten Martin; Malcovati Luca; Dybedal Ingunn; Della Porta Matteo Giovanni; Invernizzi Rosangela; Montgomery Scott M; Pascutto Cristiana; Porwit Anna; Cazzola Mario; Hellström-Lindberg Eva
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3607-13.
2008: Pellagatti Andrea; Hellström-Lindberg Eva; Giagounidis Aristoteles; Perry Janet; Malcovati Luca; Della Porta Matteo G; Jädersten Martin; Killick Sally; Fidler Carrie; Cazzola Mario; Wainscoat James S; Boultwood Jacqueline
Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
British journal of haematology 2008;142(1):57-64.
2008: Cazzola Mario; Hanania Nicola A; Jones Paul W; Mahler Donald A; Make Barry; Ohar Jill; Rennard Stephen
It's about time--directing our attention toward modifying the course of COPD.
Respiratory medicine 2008;102 Suppl 1():S37-48.
2008: Matera Maria Gabriella; Curradi Giacomo; Cazzola Mario
Long-acting beta(2) agonists in asthma and allergic rhinitis.
Expert opinion on pharmacotherapy 2008;9(9):1531-9.
2008: Andò Filippo; Ruggeri Paolo; Girbino Giuseppe; Cazzola Mario
Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
Respiratory medicine 2008;102(6):815-8.
2008: Cazzola Mario
Molecular basis of thrombocytosis.
Haematologica 2008;93(5):646-8.
2008: Angelucci Emanuele; Barosi Giovanni; Camaschella Clara; Cappellini Maria Domenica; Cazzola Mario; Galanello Renzo; Marchetti Monia; Piga Antonio; Tura Sante
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.
Haematologica 2008;93(5):741-52.
2008: Passamonti Francesco; Rumi Elisa; Caramella Marianna; Elena Chiara; Arcaini Luca; Boveri Emanuela; Del Curto Cecilia; Pietra Daniela; Vanelli Laura; Bernasconi Paolo; Pascutto Cristiana; Cazzola Mario; Morra Enrica; Lazzarino Mario
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis.
Blood 2008;111(7):3383-7.
2008: Cazzola Mario; Rogliani Paola; Curradi Giacomo
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view.
Respiratory medicine 2008;102(3):321-7.
2008: Della Porta M G; Malcovati L; Rigolin G M; Rosti V; Bonetti E; Travaglino E; Boveri E; Gallì A; Boggi S; Ciccone M; Pramparo T; Mazzini G; Invernizzi R; Lazzarino M; Cazzola M
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(3):530-7.
2008: Travaglino Erica; Benatti Chiara; Malcovati Luca; Della Porta Matteo Giovanni; Gallì Anna; Bonetti Elisa; Rosti Vittorio; Cazzola Mario; Invernizzi Rosangela
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
European journal of haematology 2008;80(3):216-26.
2008: Cazzola Mario; Gabriella Matera Maria
Cough and asthma: the role of inhaled corticosteroids and beta2-agonists.
Therapeutic advances in respiratory disease 2008;2(1):7-11.
2008: Cazzola M; MacNee W; Martinez F J; Rabe K F; Franciosi L G; Barnes P J; Brusasco V; Burge P S; Calverley P M A; Celli B R; Jones P W; Mahler D A; Make B; Miravitlles M; Page C P; Palange P; Parr D; Pistolesi M; Rennard S I; Rutten-van Mölken M P; Stockley R; Sullivan S D; Wedzicha J A; Wouters E F;
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2008;31(2):416-69.
2008: Porter John; Galanello Renzo; Saglio Giuseppe; Neufeld Ellis J; Vichinsky Elliott; Cappellini Maria Domenica; Olivieri Nancy; Piga Antonio; Cunningham Melody J; Soulières Denis; Gattermann Norbert; Tchernia Gilbert; Maertens Johan; Giardina Patricia; Kwiatkowski Janet; Quarta Giovanni; Jeng Michael; Forni Gian Luca; Stadler Michael; Cario Holger; Debusscher Louisette; Della Porta Matteo; Cazzola Mario; Greenberg Peter; Alimena Giuliana; Rabault Bertrand; Gathmann Insa; Ford John Malcolm; Alberti Daniele; Rose Christian
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology 2008;80(2):168-76.
2008: Pietra Daniela; Li Sai; Brisci Angela; Passamonti Francesco; Rumi Elisa; Theocharides Alexandre; Ferrari Maurizio; Gisslinger Heinz; Kralovics Robert; Cremonesi Laura; Skoda Radek; Cazzola Mario
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.
Blood 2008;111(3):1686-9.
2008: Malcovati Luca; Cazzola Mario
Myelodysplastic/myeloproliferative disorders.
Haematologica 2008;93(1):4-6.
2008: Boveri Emanuela; Passamonti Francesco; Rumi Elisa; Pietra Daniela; Elena Chiara; Arcaini Luca; Pascutto Cristiana; Castello Alessandro; Cazzola Mario; Magrini Umberto; Lazzarino Mario
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations.
British journal of haematology 2008;140(2):162-8.
2008: Boultwood Jacqueline; Pellagatti Andrea; Nikpour Maryam; Pushkaran Beena; Fidler Carrie; Cattan Helen; Littlewood Tim J; Malcovati Luca; Della Porta Matteo G; Jädersten Martin; Killick Sally; Giagounidis Aristoteles; Bowen David; Hellström-Lindberg Eva; Cazzola Mario; Wainscoat James S
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
PloS one 2008;3(4):e1970.
2007: Cazzola Mario
Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
Haematologica 2007;92(12):1585-9.
2007: Rumi Elisa; Passamonti Francesco; Della Porta Matteo G; Elena Chiara; Arcaini Luca; Vanelli Laura; Del Curto Cecilia; Pietra Daniela; Boveri Emanuela; Pascutto Cristiana; Cazzola Mario; Lazzarino Mario
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5630-5.
2007: Cazzola Mario; Curradi Giacomo
How to prevent relapse after acute exacerbation of asthma?
Polskie archiwum medycyny wewn?trznej 2007;117(11-12):487-90.
2007: Boultwood Jacqueline; Pellagatti Andrea; Cattan Helen; Lawrie Charles H; Giagounidis Aristoteles; Malcovati Luca; Della Porta Matteo G; Jädersten Martin; Killick Sally; Fidler Carrie; Cazzola Mario; Hellström-Lindberg Eva; Wainscoat James S
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
British journal of haematology 2007;139(4):578-89.
2007: Cazzola Mario; Matera Maria Gabriella
Safety of long-acting beta2-agonists in the treatment of asthma.
Therapeutic advances in respiratory disease 2007;1(1):35-46.
2007: Cazzola Mario; Ciaprini Chiara; Page Clive P; Matera Maria G
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease.
Expert opinion on therapeutic targets 2007;11(10):1273-86.
2007: Cazzola Mario; Matera Maria Gabriella; Rogliani Paola; Page Clive
Treating systemic effects of COPD.
Trends in pharmacological sciences 2007;28(10):544-50.
2007: Malcovati Luca; Germing Ulrich; Kuendgen Andrea; Della Porta Matteo G; Pascutto Cristiana; Invernizzi Rosangela; Giagounidis Aristoteles; Hildebrandt Barbara; Bernasconi Paolo; Knipp Sabine; Strupp Corinna; Lazzarino Mario; Aul Carlo; Cazzola Mario
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3503-10.
2007: Raimondi Gianfranco; Contini Silvia; Maria Legramante Jacopo; Bocchino Marialuisa; Sacco Sergio; Pallante Marco; Cazzola Mario; Saltini Cesare
Autonomic nervous system dysfunction in the course of active pulmonary tuberculosis.
Respiratory medicine 2007;101(8):1804-8.
2007: Santus Pierachille; Centanni Stefano; Morelli Nicoletta; Di Marco Fabiano; Verga Massimo; Cazzola Mario
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists.
Respiratory medicine 2007;101(8):1798-803.
2007: Passamonti Francesco; Randi Maria Luigia; Rumi Elisa; Pungolino Ester; Elena Chiara; Pietra Daniela; Scapin Margherita; Arcaini Luca; Tezza Fabiana; Moratti Remigio; Pascutto Cristiana; Fabris Fabrizio; Morra Enrica; Cazzola Mario; Lazzarino Mario
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.
Blood 2007;110(2):485-9.
2007: Vatrella Alessandro; Bocchino Marialuisa; Perna Francesco; Scarpa Raffaele; Galati Domenico; Spina Sergio; Pelaia Girolamo; Cazzola Mario; Sanduzzi Alessandro
Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
Respiratory medicine 2007;101(7):1383-9.
2007: Cazzola Mario; Donner Claudio F; Hanania Nicola A
One hundred years of chronic obstructive pulmonary disease (COPD).
Respiratory medicine 2007;101(6):1049-65.
2007: Mazzarella G; Ferraraccio F; Prati M V; Annunziata S; Bianco A; Mezzogiorno A; Liguori G; Angelillo I F; Cazzola M
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study.
Respiratory medicine 2007;101(6):1155-62.
2007: Cazzola Mario; Gabriella Matera Maria
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
Respiratory medicine 2007;101(5):957-62.
2007: Rumi Elisa; Passamonti Francesco; Zibellini Silvia; Martinetti Miriam; Arcaini Luca; Elena Chiara; Cazzola Mario; Lazzarino Mario
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia.
Leukemia & lymphoma 2007;48(4):805-7.
2007: Passamonti Francesco; Rumi Elisa; Pietra Daniela; Lazzarino Mario; Cazzola Mario
JAK2 (V617F) mutation in healthy individuals.
British journal of haematology 2007;136(4):678-9.
2007: Matera Maria Gabriella; Cazzola Mario
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?
Drugs 2007;67(4):503-15.
2007: Cazzola Mario; Andò Filippo; Santus Pierachille; Ruggeri Paolo; Di Marco Fabiano; Sanduzzi Alessandro; D'Amato Maria
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
Pulmonary pharmacology & therapeutics 2007;20(5):556-61.
2007: Cazzola Mario; Mantero Antonio; Santus Pierachille; Carlucci Paolo; Mondoni Michele; Bosotti Laura; Centanni Stefano
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
Pulmonary pharmacology & therapeutics 2007;20(3):258-64.
2007: Rossi Giovanni A; Cerasoli Franklin; Cazzola Mario
Safety of inhaled corticosteroids: room for improvement.
Pulmonary pharmacology & therapeutics 2007;20(1):23-35.
2006: Malcovati Luca; Della Porta Matteo Giovanni; Cazzola Mario
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome.
Haematologica 2006;91(12):1588-90.
2006: Rumi Elisa; Passamonti Francesco; Pietra Daniela; Della Porta Matteo G; Arcaini Luca; Boggi Sabrina; Elena Chiara; Boveri Emanuela; Pascutto Cristiana; Lazzarino Mario; Cazzola Mario
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.
Cancer 2006;107(9):2206-11.
2006: Di Marco Fabiano; Verga Massimo; Santus Pierachille; Morelli Nicoletta; Cazzola Mario; Centanni Stefano
Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study.
Respiratory medicine 2006;100(11):1925-32.
2006: Calabrese Cecilia; Bocchino Vincenzo; Vatrella Alessandro; Marzo Carlo; Guarino Carmine; Mascitti Sergio; Tranfa Carmelindo M E; Cazzola Mario; Micheli Pietro; Caputi Mario; Marsico Serafino A
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction.
Respiratory medicine 2006;100(8):1415-22.
2006: Pellagatti Andrea; Cazzola Mario; Giagounidis Aristoteles A N; Malcovati Luca; Porta Matteo G Della; Killick Sally; Campbell Lisa J; Wang Li; Langford Cordelia F; Fidler Carrie; Oscier David; Aul Carlo; Wainscoat James S; Boultwood Jacqueline
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Blood 2006;108(1):337-45.
2006: Santus P; Centanni S; Verga M; Di Marco F; Matera M G; Cazzola M
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation.
Respiratory medicine 2006;100(7):1277-81.
2006: Blasi F; Cazzola M; Tarsia P; Aliberti S; Baldessari C; Valenti V
Telithromycin in lower respiratory tract infections.
Future microbiology 2006;1():7-16.
2006: García Erce José Antonio; Cortés Teresa; Cremonesi Laura; Cazzola Mario; Pérez-Lungmus Gonzalo; Giralt Manual
[Hyperferritinemia-cataract syndrome associated to the HFE gene mutation. Two new Spanish families and a new mutation (A37T: "Zaragoza")]
Medicina clínica 2006;127(2):55-8.
2006: Boswell-Smith Victoria; Cazzola Mario; Page Clive P
Are phosphodiesterase 4 inhibitors just more theophylline?
The Journal of allergy and clinical immunology 2006;117(6):1237-43.
2006: Invernizzi Rosangela; Travaglino Erica; Benatti Chiara; Malcovati Luca; Della Porta Matteo; Cazzola Mario; Ascari Edoardo
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
European journal of haematology 2006;76(6):494-501.
2006: Passamonti Francesco; Rumi Elisa; Pietra Daniela; Della Porta Matteo G; Boveri Emanuela; Pascutto Cristiana; Vanelli Laura; Arcaini Luca; Burcheri Sara; Malcovati Luca; Lazzarino Mario; Cazzola Mario
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.
Blood 2006;107(9):3676-82.
2006: Pelaia Girolamo; Vatrella Alessandro; Gallelli Luca; Renda Teresa; Cazzola Mario; Maselli Rosario; Marsico Serafino A
Respiratory infections and asthma.
Respiratory medicine 2006;100(5):775-84.
2006: Della Porta M G; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(4):549-55.
2006: Cazzola Mario; Polosa Riccardo
Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
Current opinion in allergy and clinical immunology 2006;6(1):43-50.
2006: Cazzola Mario; Passamonti Francesco
Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders.
Haematologica 2006;91(2):159.
2006: Rumi Elisa; Passamonti Francesco; Boveri Emanuela; De Amici Mara; Astori Cesare; Braschi Marta; Castagnola Carlo; Magrini Umberto; Cazzola Mario; Lazzarino Mario
Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia.
American journal of hematology 2006;81(2):124-7.
2006: Ferrari Francesca; Foglieni Barbara; Arosio Paolo; Camaschella Clara; Daraio Filomena; Levi Sonia; García Erce José Antonio; Beaumont Carole; Cazzola Mario; Ferrari Maurizio; Cremonesi Laura
Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large-scale analysis of disorders of iron metabolism.
Human mutation 2006;27(2):201-8.
2006: Cazzola M; Noschese P; De Michele F; D'Amato G; Matera M G
Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
Respiratory medicine 2006;100(2):212-7.
2006: Viegi Giovanni; Pistelli Riccardo; Cazzola Mario; Falcone Franco; Cerveri Isa; Rossi Andrea; Ugo Di Maria Giuseppe
Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy.
Respiratory medicine 2006;100(1):46-55.
2006: Cazzola Mario; Hanania Nicola A
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.
International journal of chronic obstructive pulmonary disease 2006;1(4):345-54.
2006: Brown Rachel A; Allegra Luigi; Matera Maria G; Page Clive P; Cazzola Mario
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination.
Pulmonary pharmacology & therapeutics 2006;19(6):419-24.
2006: Cazzola Mario
Should the choice of a long-acting bronchodilator in the long-term therapy of chronic obstructive pulmonary disease depend entirely on the onset of action?
Respiration; international review of thoracic diseases 2006;73(4):410-1.
2006: Franciosi Luigi G; Page Clive P; Celli Bartolome R; Cazzola Mario; Walker Michael J; Danhof Meindert; Rabe Klaus F; Della Pasqua Oscar E
Markers of exacerbation severity in chronic obstructive pulmonary disease.
Respiratory research 2006;7():74.
2006: Cazzola Mario
Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine.
Treatments in respiratory medicine 2006;5(2):79-84.
2006: Cazzola Mario; Salvatori Enrica; Dionisio Paolo; Allegra Luigi
Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
Pulmonary pharmacology & therapeutics 2006;19 Suppl 1():30-7.
2006: Cazzola Mario; Donner Claudio Ferdinando
The need for a new fluoroquinolone.
Pulmonary pharmacology & therapeutics 2006;19 Suppl 1():1-3.
2006: Bellia Vincenzo; Battaglia Salvatore; Matera Maria Gabriella; Cazzola Mario
The use of bronchodilators in the treatment of airway obstruction in elderly patients.
Pulmonary pharmacology & therapeutics 2006;19(5):311-9.
2006: Franciosi Luigi G; Page Clive P; Celli Bartolome R; Cazzola Mario; Walker Michael J; Danhof Meindert; Rabe Klaus F; Della Pasqua Oscar E
Markers of disease severity in chronic obstructive pulmonary disease.
Pulmonary pharmacology & therapeutics 2006;19(3):189-99.
2006: Cazzola Mario
Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
Pulmonary pharmacology & therapeutics 2006;19(2):79-89.
2005: Cremonesi L; Forni Gian Luca; Soriani Nadia; Lamagna Martina; Fermo Isabella; Daraio Filomena; Galli Anna; Pietra Daniela; Malcovati Luca; Ferrari Maurizio; Camaschella Clara; Cazzola Mario
Genetic and clinical heterogeneity of ferroportin disease.
British journal of haematology 2005;131(5):663-70.
2005: Hanania Nicola A; Ambrosino Nicolino; Calverley Peter; Cazzola Mario; Donner Claudio F; Make Barry
Treatments for COPD.
Respiratory medicine 2005;99 Suppl B():S28-40.
2005: Kralovics Robert; Teo Soon-Siong; Buser Andreas S; Brutsche Martin; Tiedt Ralph; Tichelli Andre; Passamonti Francesco; Pietra Daniela; Cazzola Mario; Skoda Radek C
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.
Blood 2005;106(10):3374-6.
2005: Opasich Cristina; Cazzola Mario; Scelsi Laura; De Feo Stefania; Bosimini Enzo; Lagioia Rocco; Febo Oreste; Ferrari Roberto; Fucili Alessandro; Moratti Remigio; Tramarin Roberto; Tavazzi Luigi
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
European heart journal 2005;26(21):2232-7.
2005: Liccardi Gennaro; Cazzola Mario; Walter Canonica Giorgio; Passalacqua Giovanni; D'Amato Gennaro
New insights in allergen avoidance measures for mite and pet sensitized patients. A critical appraisal.
Respiratory medicine 2005;99(11):1363-76.
2005: Cazzola Mario; Matera Maria Gabriella; Donnarumma Giovanna; Tufano Maria Antonietta; Sanduzzi Alessandro; Marchetti Federico; Blasi Francesco
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.
Chest 2005;128(4):2093-8.
2005: Blasi F; Cazzola M; Tarsia P; Cosentini R; Aliberti S; Santus P; Allegra L
Azithromycin and lower respiratory tract infections.
Expert opinion on pharmacotherapy 2005;6(13):2335-51.
2005: Malcovati Luca; Porta Matteo Giovanni Della; Pascutto Cristiana; Invernizzi Rosangela; Boni Marina; Travaglino Erica; Passamonti Francesco; Arcaini Luca; Maffioli Margherita; Bernasconi Paolo; Lazzarino Mario; Cazzola Mario
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7594-603.
2005: Matera M G; Sanduzzi A; Ponticiello A; Vatrella A; Salzillo A; Cazzola M
An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.
Respiration; international review of thoracic diseases 2005;72(5):466-70.
2005: Passamonti Francesco; Rumi Elisa; Arcaini Luca; Castagnola Carlo; Lunghi Monia; Bernasconi Paolo; Giovanni Della Porta Matteo; Columbo Nora; Pascutto Cristiana; Cazzola Mario; Lazzarino Mario
Leukemic transformation of polycythemia vera: a single center study of 23 patients.
Cancer 2005;104(5):1032-6.
2005: Cazzola Mario; Matera Maria Gabriella; Lötvall Jan
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease.
Expert opinion on investigational drugs 2005;14(7):775-83.
2005: Cazzola Mario; Skoda Radek
Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders.
Haematologica 2005;90(7):871-4.
2005: Tehranchi Ramin; Invernizzi Rosangela; Grandien Alf; Zhivotovsky Boris; Fadeel Bengt; Forsblom Ann-Mari; Travaglino Erica; Samuelsson Jan; Hast Robert; Nilsson Lars; Cazzola Mario; Wibom Rolf; Hellström-Lindberg Eva
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
Blood 2005;106(1):247-53.
2005: Cazzola Mario; Salzillo Antonello; De Giglio Carlo; Piccolo Amedeo; Califano Clara; Noschese Paolo
Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
Respiratory medicine 2005;99(6):663-9.
2005: Cazzola Mario
Role of ferritin and ferroportin genes in unexplained hyperferritinaemia.
Best practice & research. Clinical haematology 2005;18(2):251-63.
2005: Liccardi Gennaro; Martín Santiago; Lombardero Manuel; D'Amato Maria; Barber Domingo; D'Amato Gennaro; Cazzola Mario
Cutaneous and serological responses to cat allergen in adults exposed or not to cats.
Respiratory medicine 2005;99(5):535-44.
2005: Cazzola Mario; Noschese Paolo; Salzillo Antonello; De Giglio Carlo; D'Amato Gennaro; Matera Maria Gabriella
Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
Respiratory medicine 2005;99(5):524-8.
2005: Malcovati L; Della Porta M G; Lunghi M; Pascutto C; Vanelli L; Travaglino E; Maffioli M; Bernasconi P; Lazzarino M; Invernizzi R; Cazzola M
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):776-83.
2005: Passamonti F; Pietra D; Rumi E; Arcaini L; Della Porta M G; Malcovati L; Pascutto C; Lazzarino M; Cazzola M
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):888-9.
2005: Kralovics Robert; Passamonti Francesco; Buser Andreas S; Teo Soon-Siong; Tiedt Ralph; Passweg Jakob R; Tichelli Andre; Cazzola Mario; Skoda Radek C
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
The New England journal of medicine 2005;352(17):1779-90.
2005: Cazzola Mario; Matera Maria Gabriella; Pezzuto Gabriella
Inflammation--a new therapeutic target in pneumonia.
Respiration; international review of thoracic diseases 2005;72(2):117-26.
2005: Liccardi Gennaro; D'Amato Gennaro; D'Amato Luciana; Salzillo Antonello; Piccolo Amedeo; De Napoli Iolanda; Dente Bruno; Cazzola Mario
The effect of pet ownership on the risk of allergic sensitisation and bronchial asthma.
Respiratory medicine 2005;99(2):227-33.
2005: Cazzola Mario; Malcovati Luca
Myelodysplastic syndromes--coping with ineffective hematopoiesis.
The New England journal of medicine 2005;352(6):536-8.
2005: Cazzola Mario; Saltini Cesare
Novel approaches to the treatment of bacterial lower respiratory tract infections: introduction.
Respiration; international review of thoracic diseases 2005;72(1):7-8.
2005: Cazzola Mario
Pyruvate kinase deficiency.
Haematologica 2005;90(1):1-2.
2005: Matera M G; Calzetta L; Peli A; Scagliarini A; Matera C; Cazzola M
Immune sensitization of equine bronchus: glutathione, IL-1beta expression and tissue responsiveness.
Respiratory research 2005;6():104.
2005: Cazzola Mario; Matera Maria G; Donner Claudio F
Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.
Drugs 2005;65(12):1595-610.
2005: Vatrella Alessandro; Ponticiello Antonio; Pelaia Girolamo; Parrella Roberto; Cazzola Mario
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma.
Pulmonary pharmacology & therapeutics 2005;18(2):89-92.
2004: Cazzola M; Centanni S; Santus P; Verga M; Mondoni M; di Marco F; Matera M G
The functional impact of adding salmeterol and tiotropium in patients with stable COPD.
Respiratory medicine 2004;98(12):1214-21.
2004: Galanello Renzo; Perseu Lucia; Perra Chiara; Maccioni Liliana; Barella Susanna; Longinotti Maurizio; Cao Antonio; Cazzola Mario
Somatic deletion of the normal beta-globin gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients.
British journal of haematology 2004;127(5):604-6.
2004: Gallí Anna; Bergamaschi Gaetano; Recalde Helios; Biasiotto Giorgio; Santambrogio Paolo; Boggi Sabrina; Levi Sonia; Arosio Paolo; Cazzola Mario
Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages.
British journal of haematology 2004;127(5):598-603.
2004: Cazzola Mario
Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?
Nature clinical practice. Oncology 2004;1(1):22-3.
2004: Passamonti Francesco; Rumi Elisa; Pungolino Ester; Malabarba Lucia; Bertazzoni Paola; Valentini Marina; Orlandi Ester; Arcaini Luca; Brusamolino Ercole; Pascutto Cristiana; Cazzola Mario; Morra Enrica; Lazzarino Mario
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.
The American journal of medicine 2004;117(10):755-61.
2004: Passamonti Francesco; Cazzola Mario
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
Haematologica 2004;89(11):1284.
2004: Invernizzi Rosangela; Travaglino Erica; Lunghi Monia; Klersy Catherine; Bernasconi Paolo; Cazzola Mario; Ascari Edoardo
Survivin expression in acute leukemias and myelodysplastic syndromes.
Leukemia & lymphoma 2004;45(11):2229-37.
2004: Cazzola Mario
Serum erythropoietin concentration as a diagnostic tool for polycythemia vera.
Haematologica 2004;89(10):1159-60.
2004: D'Amato Gennaro; Liccardi Gennaro; Noschese Paolo; Salzillo Antonello; D'Amato Maria; Cazzola Mario
Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
Current drug targets. Inflammation and allergy 2004;3(3):227-9.
2004: Passamonti Francesco; Pietra Daniela; Malabarba Lucia; Rumi Elisa; Della Porta Matteo Giovanni; Malcovati Luca; Bonfichi Maurizio; Pascutto Cristiana; Lazzarino Mario; Cazzola Mario
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.
British journal of haematology 2004;126(5):650-6.
2004: Passamonti Francesco; Rumi Elisa; Malabarba Lucia; Arcaini Luca; Orlandi Ester; Brusamolino Ercole; Pascutto Cristiana; Cazzola Mario; Lazzarino Mario
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.
Annals of hematology 2004;83(8):495-7.
2004: Bergamaschi Gaetano; Merante Serena; Orlandi Ester; Galli Anna; Bernasconi Paolo; Cazzola Mario
TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.
Haematologica 2004;89(7):868-9.
2004: Cazzola Mario; Dahl Ronald
Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
Chest 2004;126(1):220-37.
2004: Lanzara Carmela; Roetto Antonella; Daraio Filomena; Rivard Silvain; Ficarella Romina; Simard Hervey; Cox Timothy M; Cazzola Mario; Piperno Alberto; Gimenez-Roqueplo Anne-Paule; Grammatico Paola; Volinia Stefano; Gasparini Paolo; Camaschella Clara
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.
Blood 2004;103(11):4317-21.
2004: Cazzola Mario; Page Clive Peter; Matera Maria Gabriella
Alternative and/or integrative therapies for pneumonia under development.
Current opinion in pulmonary medicine 2004;10(3):204-10.
2004: Malcovati Luca; La Starza Roberta; Merante Serena; Pietra Daniela; Mecucci Cristina; Cazzola Mario
Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cell.
Haematologica 2004;89(4):497-9.
2004: Cazzola Mario; Matera Maria Gabriella; Ruggeri Paolo; Sanduzzi Alessandro; Spicuzza Lucia; Vatrella Alessandro; Girbino Giuseppe
Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
Respiration; international review of thoracic diseases 2004;71(2):159-64.
2004: Roetto Antonella; Daraio Filomena; Porporato Paolo; Caruso Roberta; Cox Timothy M; Cazzola Mario; Gasparini Paolo; Piperno Alberto; Camaschella Clara
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R).
Blood 2004;103(6):2407-9.
2004: Cazzola Mario
Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices.
Haematologica 2004;89(2):137-8.
2004: Cazzola Mario; Matera Maria Gabriella; Blasi Francesco
Macrolide and occult infection in asthma.
Current opinion in pulmonary medicine 2004;10(1):7-14.
2004: Cazzola Mario; Matera Maria Gabriella
Long-acting bronchodilators are the first-choice option for the treatment of stable COPD.
Chest 2004;125(1):9-11.
2004: Pelaia Girolamo; Vatrella Alessandro; Gallelli Luca; Cazzola Mario; Maselli Rosario; Marsico Serafino A
Potential genetic influences on the response to asthma treatment.
Pulmonary pharmacology & therapeutics 2004;17(5):253-61.
2004: Cazzola Mario
Erythropoietin pathophysiology and erythropoietin deficiency anemia.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5 Suppl 3():S100-3.
2004: Cazzola Mario; Noschese Paolo; Centanni Stefano; Santus Pierachile; Di Marco Fabiano; Spicuzza Lucia; Di Maria Giuseppe Ugo
Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD.
Pulmonary pharmacology & therapeutics 2004;17(3):141-5.
2004: Cazzola M; Santus P; Di Marco F; Carlucci P; Mondoni M; Matera M G; Centanni S
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD.
Pulmonary pharmacology & therapeutics 2004;17(3):121-5.
2004: Cazzola Mario; Di Marco Fabiano; Santus Pierachille; Boveri Barbara; Verga Massimo; Matera Maria Gabriella; Centanni Stefano
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.
Pulmonary pharmacology & therapeutics 2004;17(1):35-9.
2003: Passamonti Francesco; Vanelli Laura; Malabarba Lucia; Rumi Elisa; Pungolino Ester; Malcovati Luca; Pascutto Cristiana; Morra Enrica; Lazzarino Mario; Cazzola Mario
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
Haematologica 2003;88(10):1123-9.
2003: Cazzola Mario; Beguin Yves; Kloczko Janusz; Spicka Ivan; Coiffier Bertrand
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
British journal of haematology 2003;122(3):386-93.
2003: Cazzola Mario
Genetic disorders of iron overload and the novel "ferroportin disease".
Haematologica 2003;88(7):721-4.
2003: Liccardi G; Cazzola M; Canonica G W; D'Amato M; D'Amato G; Passalacqua G
General strategy for the management of bronchial asthma in pregnancy.
Respiratory medicine 2003;97(7):778-89.
2003: Blasi Francesco; Tarsia Paolo; Cosentini Roberto; Cazzola Mario; Allegra Luigi
Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.
Expert opinion on investigational drugs 2003;12(7):1165-77.
2003: Cremonesi Laura; Stenirri Stefania; Fermo Isabella; Paroni Rita; Ferrari Maurizio; Cazzola Mario; Arosio Paolo
Denaturing HPLC analysis of DNA deletions and insertions.
Human mutation 2003;22(1):98-102.
2003: Cazzola Mario; Matera Maria G; Page Clive P
Novel approaches to the treatment of pneumonia.
Trends in pharmacological sciences 2003;24(6):306-14.
2003: Cazzola Mario
Erythropoietin therapy: need for rationality and active surveillance.
Haematologica 2003;88(6):601-5.
2003: Malcovati Luca; Pascutto Cristiana; Cazzola Mario
Hematologic passport for athletes competing in endurance sports: a feasibility study.
Haematologica 2003;88(5):570-81.
2003: Cazzola M; Santus P; Matera M G; Carlucci P; Belloli E; Di Marco F; Centanni S
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD.
Respiratory medicine 2003;97(5):458-62.
2003: Cazzola M; Santus P; Di Marco F; Boveri B; Castagna F; Carlucci P; Matera M G; Centanni S
Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.
Respiratory medicine 2003;97(5):453-7.
2003: Cremonesi Laura; Paroni Rita; Foglieni Barbara; Galbiati Silvia; Fermo Isabella; Soriani Nadia; Belloli Silvana; Ruggeri Giuseppina; Biasiotto Giorgio; Cazzola Mario; Ferrari Francesca; Ferrari Maurizio; Arosio Paolo
Scanning mutations of the 5'UTR regulatory sequence of L-ferritin by denaturing high-performance liquid chromatography: identification of new mutations.
British journal of haematology 2003;121(1):173-9.
2003: Cazzola Mario; Invernizzi Rosangela; Bergamaschi Gaetano; Levi Sonia; Corsi Barbara; Travaglino Erica; Rolandi Valeria; Biasiotto Giorgio; Drysdale Jim; Arosio Paolo
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
Blood 2003;101(5):1996-2000.
2003: Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(1):86-94.
2003: Cazzola Mario; Matera Maria Gabriella
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
Pulmonary pharmacology & therapeutics 2003;16(4):197-201.
2003: Cazzola Mario; Sanduzzi Alessandro; Matera Maria Gabriella
Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infections.
Pulmonary pharmacology & therapeutics 2003;16(3):131-45.
2003: Cazzola Mario; Matera Maria Gabriella; D'Amato Maria; Califano Clara; Sanduzzi Alessandro; Vatrella Alessandro; D'Amato Gennaro
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler.
Pulmonary pharmacology & therapeutics 2003;16(2):105-9.
2002: Alessandrino Emilio Paolo; Amadori Sergio; Barosi Giovanni; Cazzola Mario; Grossi Alberto; Liberato Lucio N; Locatelli Franco; Marchetti Monia; Morra Enrica; Rebulla Paolo; Visani Giuseppe; Tura Sante;
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Haematologica 2002;87(12):1286-306.
2002: Cazzola Mario
Practice guidelines for the therapy of primary myelodysplastic syndromes: a word of caution about their translation into clinical practice.
Haematologica 2002;87(12):1240-1.
2002: Cazzola Mario; May Alison; Bergamaschi Gaetano; Cerani Paola; Ferrillo Sara; Bishop David F
Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation.
Blood 2002;100(12):4236-8.
2002: Drysdale Jim; Arosio Paolo; Invernizzi Rosangela; Cazzola Mario; Volz Armin; Corsi Barbara; Biasiotto Giorgio; Levi Sonia
Mitochondrial ferritin: a new player in iron metabolism.
Blood cells, molecules & diseases 2002;29(3):376-83.
2002: Cazzola Mario; Cremonesi Laura; Papaioannou Maria; Soriani Nadia; Kioumi Anna; Charalambidou Anastasia; Paroni Rita; Romtsou Katerina; Levi Sonia; Ferrari Maurizio; Arosio Paolo; Christakis John
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).
British journal of haematology 2002;119(2):539-46.
2002: Cazzola M; Califano C; Di Perna F; D'Amato M; Terzano C; Matera M G; D'Amato G; Marsico S A
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.
Respiratory medicine 2002;96(10):790-5.
2002: Cazzola M; Noschese P; Salzillo A; Piccolo A
Asthma treatment must be always tailored to the individual patient.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2002;57(3-4):213-7.
2002: Cazzola Mario
Hereditary hyperferritinaemia/ cataract syndrome.
Best practice & research. Clinical haematology 2002;15(2):385-98.
2002: Cazzola M; Santus P; Castagna F; Di Marco F; Terzano C; Matera M G; Centanni S
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD.
Respiratory medicine 2002;96(6):439-43.
2002: De Gobbi Marco; Roetto Antonella; Piperno Alberto; Mariani Raffaella; Alberti Federica; Papanikolaou George; Politou Marianna; Lockitch Gillian; Girelli Domenico; Fargion Silvia; Cox Thimoty M; Gasparini Paolo; Cazzola Mario; Camaschella Clara
Natural history of juvenile haemochromatosis.
British journal of haematology 2002;117(4):973-9.
2002: Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera M G; D'Amato G
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
Clinical therapeutics 2002;24(4):595-604.
2002: Blasi Francesco; Braga Piercarlo; Cazzola Mario; Cosentini Roberto; Tarsia Paolo
Therapies in development for community-acquired pneumonia.
Expert opinion on investigational drugs 2002;11(4):545-52.
2002: Centanni S; Santus P; Casanova F; Carlucci P; Boveri B; Castagna F; Di Marco F; Cazzola M
Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study.
Respiratory medicine 2002;96(3):137-41.
2002: Passamonti Francesco; Malabarba Lucia; Orlandi Ester; Pascutto Cristiana; Brusamolino Ercole; Astori Cesare; Baratè Claudia; Canevari Angelo; Corso Alessandro; Bernasconi Paolo; Cazzola Mario; Lazzarino Mario
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
British journal of haematology 2002;116(4):855-61.
2002: Cazzola Mario
Further concerns about the medical risks of blood doping.
Haematologica 2002;87(3):232.
2002: Cazzola Mario; Foglieni Barbara; Bergamaschi Gaetano; Levi Sonia; Lazzarino Mario; Arosio Paolo
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome.
British journal of haematology 2002;116(3):667-70.
2002: Cazzola Mario
Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thought.
Haematologica 2002;87(2):115-6.
2002: Cazzola Mario; Noschese Paolo; D'Amato Gennaro; Matera Maria Gabriella
The pharmacologic treatment of uncomplicated arterial hypertension in patients with airway dysfunction.
Chest 2002;121(1):230-41.
2002: Cazzola Mario; Blasi Francesco; Terzano Claudio; Matera Maria G; Marsico Serafino A
Delivering antibacterials to the lungs: considerations for optimizing outcomes.
American journal of respiratory medicine : drugs, devices, and other interventions 2002;1(4):261-72.
2002: Cazzola M; Grella E; Matera M G; Mazzarella G; Marsico S A
Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction.
Pulmonary pharmacology & therapeutics 2002;15(2):97-102.
2002: Cazzola Mario; Testi Renato; Matera Maria Gabriella
Clinical pharmacokinetics of salmeterol.
Clinical pharmacokinetics 2002;41(1):19-30.
2001: Cazzola M; Di Perna F; D'Amato M; Califano C; Matera M G; D'Amato G
Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.
Respiratory medicine 2001;95(11):917-21.
2001: Alessandrino E P; Amadori S; Cazzola M; Locatelli F; Mecucci C; Morra E; Saglio G; Visani G; Tura S
Myelodysplastic syndromes: recent advances.
Haematologica 2001;86(11):1124-57.
2001: Bergamaschi G; Rolandi V; Cazzola M
Differential HFE allele expression in hemochromatosis heterozygotes.
Gastroenterology 2001;120(5):1308-9.
2001: Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera M G; Allegra L
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Respiration; international review of thoracic diseases 2001;68(5):452-9.
2001: Cazzola M; Blasi F; Centanni S; Donner C F; Allegra L
Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections.
Pulmonary pharmacology & therapeutics 2001;14(5):367-81.
2001: Cazzola M; Centanni S; Regorda C; di Marco F; di Perna F; Carlucci P; Boveri B; Santus P
Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.
Pulmonary pharmacology & therapeutics 2001;14(1):41-5.
2000: Cazzola M; Di Lorenzo G; Di Perna F; Calderaro F; Testi R; Centanni S
Additive effects of salmeterol and fluticasone or theophylline in COPD.
Chest 2000;118(6):1576-81.
2000: Cazzola M; May A; Bergamaschi G; Cerani P; Rosti V; Bishop D F
Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.
Blood 2000;96(13):4363-5.
2000: Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
Haematologica 2000;85(11 Suppl):18-25.
2000: Cazzola M
Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Medical oncology (Northwood, London, England) 2000;17 Suppl 1():S11-6.
2000: Cazzola M
Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
International journal of hematology 2000;72(2):134-8.
2000: Cazzola M; Donner C F
Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
Drugs 2000;60(2):307-20.
2000: Roetto A; Alberti F; Daraio F; Cali A; Cazzola M; Totaro A; Gasparini P; Camaschella C
Exclusion of ZIRTL as candidate gene of juvenile hemochromatosis and refinement of the critical interval on 1q21.
Blood cells, molecules & diseases 2000;26(3):205-10.
2000: Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Journal of chemotherapy (Florence, Italy) 2000;12(3):216-22.
2000: Cazzola M; Skoda R C
Translational pathophysiology: a novel molecular mechanism of human disease.
Blood 2000;95(11):3280-8.
2000: Lucotti C; Malabarba L; Rosti V; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Ramajoli I; Perotti C; Torretta L; De Amici M; Salvaneschi L; Cazzola M
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle.
British journal of haematology 2000;108(3):621-8.
2000: Cazzola M; Boveri B; Carlucci P; Santus P; DiMarco F; Centanni S; Allegra L
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Pulmonary pharmacology & therapeutics 2000;13(6):301-5.
2000: Cazzola M; Matera M G; Noschese P
Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.
Pulmonary pharmacology & therapeutics 2000;13(6):249-56.
2000: Centanni S; Carlucci P; Santus P; Boveri B; Tarricone D; Fiorentini C; Lombardi F; Cazzola M
Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma.
Respiration; international review of thoracic diseases 2000;67(1):60-4.
2000: Rosti V; Lucotti C; Cazzola M; Bergamaschi G
Inhibition of c-ABL expression in hematopoietic progenitor cells using antisense oligodeoxynucleotides.
Methods in enzymology 2000;314():429-40.
1999: Cazzola M; Matera M G; Di Perna E; Califano C; D'Amato M; Mazzarella G
Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
Respiratory medicine 1999;93(12):909-11.
1999: Cazzola M; Di Perna F; Centanni S; Califano C; Donner C F; D'Amato M; D'Amato G
Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
Thorax 1999;54(12):1083-6.
1999: Cazzola M; Beguin Y; Bergamaschi G; Guarnone R; Cerani P; Barella S; Cao A; Galanello R
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis.
British journal of haematology 1999;106(3):752-5.
1999: Cerutti A; Custodi P; Mduranti; Cazzola M; Balduini C L
Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.
Clinical and laboratory haematology 1999;21(4):271-5.
1999: Roetto A; Totaro A; Cazzola M; Cicilano M; Bosio S; D'Ascola G; Carella M; Zelante L; Kelly A L; Cox T M; Gasparini P; Camaschella C
Juvenile hemochromatosis locus maps to chromosome 1q.
American journal of human genetics 1999;64(5):1388-93.
1999: Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Journal of chemotherapy (Florence, Italy) 1999;11(2):119-25.
1999: Rovati A; Bergamaschi G; Casula S; Cerani P; Grasso M; Cazzola M
The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis.
Haematologica 1999;84(2):182-3.
1999: Cazzola M
Haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Forum (Genoa, Italy) 1999;9(1):49-57.
1999: Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner C F; Matera M G
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
European journal of clinical pharmacology 1999;54(11):829-33.
1999: Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
Pulmonary pharmacology & therapeutics 1999;12(4):267-71.
1998: Cazzola M; Centanni S; Donner C F
Anticholinergic agents.
Pulmonary pharmacology & therapeutics 1998;11(5-6):381-92.
1998: Cazzola M; Anderson J E; Ganser A; Hellström-Lindberg E
A patient-oriented approach to treatment of myelodysplastic syndromes.
Haematologica 1998;83(10):910-35.
1998: Cazzola M; Cerani P; Rovati A; Iannone A; Claudiani G; Bergamaschi G
Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder.
Blood 1998;92(8):2979-81.
1998: Tonon L; Bergamaschi G; Dellavecchia C; Rosti V; Lucotti C; Malabarba L; Novella A; Vercesi E; Frassoni F; Cazzola M
Unbalanced X-chromosome inactivation in haemopoietic cells from normal women.
British journal of haematology 1998;102(4):996-1003.
1998: Cazzola M; Vinciguerra A; Di Perna F; Matera M G
Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
Respiratory medicine 1998;92(8):1012-6.
1998: Cazzola M; Imperatore F; Salzillo A; Di Perna F; Calderaro F; Imperatore A; Matera M G
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
Chest 1998;114(2):411-5.
1998: Cazzola M; Matera M G
Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis.
Respiratory medicine 1998;92(7):895-901.
1998: Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera M G
Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1998;11(6):1337-41.
1998: Cazzola M; Guarnone R; Cerani P; Centenara E; Rovati A; Beguin Y
Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
Blood 1998;91(6):2139-45.
1998: Cazzola M; Matera M G; Di Perna F; Calderaro F; Califano C; Vinciguerra A
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
Respiratory medicine 1998;92(2):354-7.
1998: Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
[Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage]
Minerva medica 1998;89(1-2):15-22.
1998: Cazzola M; Guarnone R; Cerani P; Rovati A; Ascari E
Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.
Blood 1998;91(1):360-1.
1997: Ponchio L; Eaves C; Hogge D; Perotti C; Torretta L; Cerani P; Salvaneschi L; Ascari E; Cazzola M
Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF.
British journal of haematology 1997;99(2):394-402.
1997: Novella A; Bergamaschi G; Canale C; Fossati G; Gritti D; Lucotti C; Mazzone A; Tonon L; Cazzola M
Expression of adhesion molecules and functional stimulation in human neutrophils: modulation by GM-CSF and role of the Bcr gene.
British journal of haematology 1997;98(3):621-6.
1997: Cazzola M; Caputi M; Santangelo G; Diu Vinciguerra A; Perna F D; Polverino M
A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease.
Journal of chemotherapy (Florence, Italy) 1997;9(4):279-84.
1997: Cazzola M; Bergamaschi G; Tonon L; Arbustini E; Grasso M; Vercesi E; Barosi G; Bianchi P E; Cairo G; Arosio P
Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA.
Blood 1997;90(2):814-21.
1997: Cazzola M; Spina D; Matera M G
The use of bronchodilators in stable chronic obstructive pulmonary disease.
Pulmonary pharmacology & therapeutics 1997;10(3):129-44.
1997: Cazzola M; Mercuriali F; Brugnara C
Use of recombinant human erythropoietin outside the setting of uremia.
Blood 1997;89(12):4248-67.
1997: Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Transfusion 1997;37(2):135-40.
1996: Invernizzi R; Bergamaschi G; Cazzola M
Acute promyelocytic leukemia complicating chemo-radiotherapy for multiple myeloma.
Haematologica 1996;81(5):483.
1996: Cazzola M; Ponchio L; Pedrotti C; Farina G; Cerani P; Lucotti C; Novella A; Rovati A; Bergamaschi G; Beguin Y
Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.
Haematologica 1996;81(5):434-41.
1996: Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie M J; Merlini G; Cazzola M
Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
British journal of haematology 1996;93(4):789-94.
1996: Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Blood 1996;87(11):4824-30.
1996: D'Agostino B; Matera M G; Cazzola M; Mangrella M; Rossi F
Effects of in vitro 5-HT1 receptor activation in guinea pig trachea.
Life sciences 1996;59(2):153-60.
1995: Matera M G; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Pulmonary pharmacology 1995;8(6):267-71.
1995: Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Blood 1995;86(12):4446-53.
1995: Rosti V; Bergamaschi G; Lucotti C; Danova M; Carlo-Stella C; Locatelli F; Tonon L; Mazzini G; Cazzola M
Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
Blood 1995;86(9):3387-93.
1995: Cazzola M; Vinciguerra A; Beghi G F; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli G F; Tonna M; Casalini A
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Journal of chemotherapy (Florence, Italy) 1995;7(5):432-41.
1995: Losasso C; Loffreda A; Angrisani M; Contaldi C; Cazzola M; Rossi F
Effects of lomefloxacin and sparfloxacin on human platelet aggregation.
Journal of chemotherapy (Florence, Italy) 1995;7(5):420-3.
1995: Paulli M; Bergamaschi G; Tonon L; Viglio A; Rosso R; Facchetti F; Geerts M L; Magrini U; Cazzola M
Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
British journal of haematology 1995;91(2):415-8.
1995: Cazzola M; Matera M G; Santangelo G; Vinciguerra A; Rossi F; D'Amato G
Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.
Respiratory medicine 1995;89(5):357-62.
1995: Zecca M; Rosti V; Pinto L; Comoli P; Carrà A M; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
Medical and pediatric oncology 1995;24(3):166-70.
1995: Cazzola M; De Stefano P; Ponchio L; Locatelli F; Beguin Y; Dessi C; Barella S; Cao A; Galanello R
Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.
British journal of haematology 1995;89(3):473-8.
1995: Matera M G; De Santis D; D'Agostino B; Pallotta M; Vacca C; Cazzola M; Rossi F
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contraction.
Immunopharmacology 1995;29(1):73-8.
1995: D'Amato G; Kordash T R; Liccardi G; Lobefalo G; Cazzola M; Freshwater L L
Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-blind placebo-controlled study.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(2):149-58.
1995: D'Amato G; Lobefalo G; Liccardi G; Cazzola M
A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(2):141-8.
1995: Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
Pulmonary penetration of ceftazidime.
Journal of chemotherapy (Florence, Italy) 1995;7(1):50-4.
1995: Cazzola M; Santangelo G; Angrisani M; Vinciguerra A; Contaldi C; Rossi F
Evaluation of the effects of pefloxacin on platelet aggregation in vitro and ex vivo in patients suffering from chronic bronchitis.
Journal of chemotherapy (Florence, Italy) 1995;7(1):38-41.
1995: Cazzola M; Matera M G; D'Amato G; Rossi F
Effects of serotonin on airways: recent developments.
Allergy 1995;50(1):1-10.
1994: Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14(6):929-35.
1994: Martini A; Ravelli A; Di Fuccia G; Rosti V; Cazzola M; Barosi G
Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis.
Lancet 1994;344(8929):1052-4.
1994: Bergamaschi G; Podestà M; Frassoni F; Rosti V; Carella A M; Saglio G; Cazzola M
Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells.
British journal of haematology 1994;87(4):867-70.
1994: Cazzola M
Problems and prospectives in the antibiotic treatment of lower respiratory tract infections.
Pulmonary pharmacology 1994;7(3):139-52.
1994: Locatelli F; Pession A; Bonetti F; Maserati E; Prete L; Pedrazzoli P; Zecca M; Prete A; Paolucci P; Cazzola M
Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(5):844-9.
1994: Cazzola M; Matera M G; Liccardi G; Sacerdoti G; D'Amato G; Rossi F
Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.
Pulmonary pharmacology 1994;7(2):91-7.
1994: Cazzola M; Santangelo G; Piccolo A; Salzillo A; Matera M G; D'Amato G; Rossi F
Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.
Pulmonary pharmacology 1994;7(2):103-7.
1994: Cazzola M; Matera M G; Santangelo G; Angrisani M; Loffreda A; de Prisco F; Paizis G; Rossi F
Serum digoxin levels after concomitant ticarcillin and clavulanic acid administration.
Therapeutic drug monitoring 1994;16(1):46-8.
1994: Cazzola M; Siniscalchi C; Vinciguerra A; Santangelo G; Matera M G; Rossi F
Evaluation of lung tissue and hilar lymph node concentrations of azithromycin.
International journal of clinical pharmacology and therapeutics 1994;32(2):88-91.
1994: Bergamaschi G; Rosti V; Danova M; Lucotti C; Cazzola M
Apoptosis: biological and clinical aspects.
Haematologica 1994;79(1):86-93.
1993: Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(12):2012-8.
1993: Rosti V; Bergamaschi G; Lucotti C; Cazzola M
C-fms expression in B-cells and response to M-CSF.
British journal of haematology 1993;84(4):755-6.
1993: Matera M G; Cazzola M; Lampa E; Santangelo G; Paizis G; Vinciguerra A; Rossi F
Clinical pharmacokinetics of theophylline during co-treatment with ticarcillin plus clavulanic acid in patients suffering from acute exacerbation of chronic bronchitis.
Journal of chemotherapy (Florence, Italy) 1993;5(4):233-6.
1993: Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
British journal of haematology 1993;84(4):752-4.
1993: Rosti V; Pedrazzoli P; Ponchio L; Zibera C; Novella A; Lucotti C; Della Cuna G R; Cazzola M
Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro.
Haematologica 1993;78(4):208-12.
1993: Cazzola M; Brancaccio V; De Giglio C; Paternò E; Matera M G; Rossi F
Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects.
International journal of clinical pharmacology, therapy, and toxicology 1993;31(3):148-52.
1993: Angrisani M; Cazzola M; Loffreda A; Matera M G; Rossi F
Teicoplanin with other drugs: possible pharmacological interactions.
Journal of chemotherapy (Florence, Italy) 1993;5(1):22-6.
1993: Bergamaschi G; Recalde H H; Ponchio L; Rosti V; Cazzola M
Erythrophagocytosis increases the expression of erythroid potentiating activity mRNA in human monocyte-macrophages.
Experimental hematology 1993;21(1):70-3.
1993: Cazzola M; Matera M G; Santangelo G; Lampa E; Angrisani M; Loffreda A; Rossi F
Effects of some cephalosporins and teicoplanin on platelet aggregation.
International journal of clinical pharmacology research 1993;13(2):69-73.
1993: Matera M G; Cazzola M; Rossi F
Role of M1 muscarinic receptor subtypes in mediating airway smooth muscle contraction.
International journal of tissue reactions 1993;15(1):31-5.
1993: Cazzola M; Matera M G; Liccardi G; De Prisco F; D'Amato G; Rossi F
Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough.
Respiration; international review of thoracic diseases 1993;60(4):212-5.
1992: Cazzola M; Ponchio L; Rosti V; Farina G; Pedrotti C; Bergamaschi G
Diagnostic approach to the myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():19-22.
1992: Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Haematologica 1992;77(6):494-501.
1992: Matera M G; Cazzola M; Costantino M; Lampa E; Rossi F
Role of 5-HT2 receptor subtypes in mediating adenosine-induced airway contraction.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():40-1.
1992: Matera M G; Cazzola M; Constantino M; De Santis D; Rossi F
Responsiveness and sensitivity to cholinergic agonists and antagonists in bovine isolated bronchial muscle.
Clinical and experimental pharmacology & physiology 1992;19(9):627-30.
1992: Rossi F; Santangelo G; Loffreda A; Angrisani M; Matera C; Cazzola M
Effects of teicoplanin on human platelet aggregation in vitro and ex vivo.
Journal of chemotherapy (Florence, Italy) 1992;4(3):159-62.
1992: Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
British journal of haematology 1992;80(4):545-9.
1992: Cazzola M; Beguin Y
New tools for clinical evaluation of erythron function in man.
British journal of haematology 1992;80(3):278-84.
1992: Rosti V; Bergamaschi G; Ponchio L; Cazzola M
c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(1):1-7.
1992: Cazzola M; Ponchio L; Beguin Y; Rosti V; Bergamaschi G; Liberato N L; Fregoni V; Nalli G; Barosi G; Ascari E
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.
Blood 1992;79(1):29-37.
1992: Cazzola M; Matera M G; Santangelo G; Assogna G; D'Amato G; Rossi F; Girbino G
Effect of the selective 5-HT2 antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects.
Immunopharmacology 1992;23(1):21-8.
1992: Angrisani M; Cazzola M; Loffreda A; Losasso C; Lucarelli C; Rossi F
Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both medicaments.
International journal of clinical pharmacology research 1992;12(4):165-71.
1991: Barosi G; Buratti A; Costa A; Liberato L N; Balduini C; Cazzola M; Rosti V; Magrini U; Ascari E
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.
Cancer 1991;68(10):2310-8.
1991: Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali F A; Della Valle G; Rossi Ferrini P; Ascari E
Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(10):886-91.
1991: Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
Journal of chemotherapy (Florence, Italy) 1991;3(4):245-9.
1991: Cazzola M; Matera M G; Paternò E; Scaglione F; Santangelo G; Rossi F
Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
Journal of chemotherapy (Florence, Italy) 1991;3(4):240-4.
1991: Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cancer research 1991;51(2):536-41.
1991: Cazzola M; Matera M G; Rossi F
Bronchial hyperresponsiveness and bacterial respiratory infections.
Clinical therapeutics 1991;13(1):157-71.
1991: Cazzola M; Santangelo G; Martucci P; Caputi M
An in vitro study of the possible interaction between human platelets and cephalosporins.
International journal of clinical pharmacology research 1991;11(1):7-10.
1991: Cazzola M; Santangelo G; Guidetti E; Mattina R; Caputi M; Girbino G
Influence of sulbactam plus ampicillin on theophylline clearance.
International journal of clinical pharmacology research 1991;11(1):11-5.
1991: Cazzola M; Santangelo G; Paizis G; Matera C; Rossi F
Effects of cefonicid on platelet aggregation.
Drugs under experimental and clinical research 1991;17(2):105-8.
1991: Cazzola M; Bergamaschi G; Dezza L; Ponchio L; Rosti V; Zappone E; Ascari E
Role of iron and proteins of iron metabolism in cell growth. Potential for manipulations of cellular iron metabolism in modulating cell proliferation.
Current studies in hematology and blood transfusion 1991;(58):153-7.
1990: Invernizzi R; Cazzola M; De Fazio P; Rosti V; Ruggeri G; Arosio P
Immunocytochemical detection of ferritin in human bone marrow and peripheral blood cells using monoclonal antibodies specific for the H and L subunit.
British journal of haematology 1990;76(3):427-32.
1990: Cazzola M; Bergamaschi G; Melazzini M; Ponchio L; Rosti V; Molinari E
Chronic myelogenous leukemia following radiotherapy and chemotherapy for non-Hodgkin lymphoma.
Haematologica 1990;75(5):477-9.
1990: Cazzola M; Pedrazzoli P; Bergamaschi G; Buonanno C; Cuomo A; D'Uva R; Ponchio L; Rosti V; Zappone E; Ascari E
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons]
Haematologica 1990;75 Suppl 4():20-7.
1990: Bergamaschi G; Carlo-Stella C; Cazzola M; De Fazio P; Pedrazzoli P; Peverali F A; Della Valle G
Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(6):426-30.
1990: Bergamaschi G; Bergamaschi P; Carlevati S; Cazzola M
Transferrin receptor expression in the human placenta.
Haematologica 1990;75(3):220-3.
1990: Cazzola M; Bergamaschi G; Dezza L; Arosio P
Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects.
Blood 1990;75(10):1903-19.
1990: Cazzola M; Guidetti E; Sepe J; Assogna G; Lucchetti G; Santangelo G; D'Amato G
Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin.
Chest 1990;97(4):901-5.
1990: Cassano E; Giordano M; Riccardi A; Coci A; Cazzola M
Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system.
Haematologica 1990;75(2):141-5.
1990: Cazzola M; Ariano R; Gioia V; Mancini V; Rimoldi R; Scala G; Scoccia S; Girbino G
Bacterial isolates and cigarette smoking in patients with chronic bronchitis: results from an Italian multicenter survey.
Clinical therapeutics 1990;12(2):105-17.
1990: Cazzola M; Assogna G; Lucchetti G; Cicchitto G; D'Amato G
Effect of ketanserin, a new blocking agent of the 5-HT2 receptor, on airway responsiveness in asthma.
Allergy 1990;45(2):151-3.
1990: Cazzola M; Polverino M; Guidetti E; Santangelo G; Paizis G; Monaco G; D'Amato G; Girbino G
Penetration of cefonicid into human lung tissue and lymph nodes.
Chemotherapy 1990;36(5):325-31.
1990: Cazzola M; D'Amato G; Guidetti E; Staudinger H; Steinijans V W; Kilian U
An M1-selective muscarinic receptor antagonist telenzepine improves lung function in patients with chronic obstructive bronchitis.
Pulmonary pharmacology 1990;3(4):185-9.
1990: Cazzola M; Spinazzi A; Santangelo G; Steinijans V W; Wurst W; Solleder P; Girbino G
Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.
Drugs 1990;40 Suppl 4():71-2.
1989: D'Amato G; Lobefalo G; Cazzola M; Cicchitto G
[Bronchial reactivity tests]
Archivio Monaldi per le malattie del torace 1989;44(4-6):1011-20.
1989: Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(5):363-6.
1989: Carlo-Stella C; Cazzola M; Bernasconi P; Bergamaschi G; Dezza L; Pedrazzoli P; Rosti V; Tomaselli S; Zappone E
In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Haematologica 1989;74(2):181-6.
1989: Dezza L; Cazzola M; Danova M; Carlo-Stella C; Bergamaschi G; Brugnatelli S; Invernizzi R; Mazzini G; Riccardi A; Ascari E
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(2):104-7.
1989: Cazzola M; Matera M G; D'Amato G; De Novellis V; Marmo E
Muscarinic M-1 receptors mediate the bronchial hyperresponsiveness during methacholine inhalation.
International journal of clinical pharmacology research 1989;9(1):71-6.
1989: Cazzola M; Matera M G; D'Amato G; De Santis D; Maione S; Lisa M; Cenicola M L; Marmo E
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients.
International journal of clinical pharmacology research 1989;9(1):65-70.
1989: Cazzola M; Finch C A
Iron balance in thalassemia.
Progress in clinical and biological research 1989;309():93-100.
1989: Cazzola M; Lobefalo G; Lupis F; Vanacore L; Martucci P; D'Amato G
The effects of cefonicid on the pharmacokinetics of a once-a-day theophylline formulation.
International journal of clinical pharmacology research 1989;9(3):169-73.
1988: Carlo-Stella C; Cazzola M; Ganser A; Bergamaschi G; Pedrazzoli P; Hoelzer D; Ascari E
Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM).
Blood 1988;72(4):1293-9.
1988: Giordano M; Ucci G; Riccardi A; Girino M; Danova M; Stella C C; Pedrazzoli P; Cazzola M
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells.
Haematologica 1988;73(3):187-9.
1988: Dezza L; Cazzola M; Bergamaschi G; Stella C C; Pedrazzoli P; Recalde H R
Effects of recombinant human H-subunit and L-subunit ferritins on in vitro growth of human granulocyte-monocyte progenitors.
British journal of haematology 1988;68(3):367-72.
1988: Bergamaschi G; Cazzola M; Dezza L; Savino E; Consonni L; Lappi D
Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6).
British journal of haematology 1988;68(3):379-84.
1988: Riccardi A; Giordano M; Giordano P; Cassano E; Girino M; Cazzola M; Scivetti P; Danova M; Ucci G
Prognostic parameters in myelodysplastic syndromes: a multiple regression analysis.
European journal of haematology 1988;40(2):158-62.
1988: Cazzola M; Barosi G; Gobbi P G; Invernizzi R; Riccardi A; Ascari E
Natural history of idiopathic refractory sideroblastic anemia.
Blood 1988;71(2):305-12.
1988: Stella C C; Bergamaschi G; Nalli G; Cazzola M
"In vitro" megakaryocytopoiesis in patients with HIV-related thrombocytopenic purpura.
Haematologica 1988;73(1):25-30.
1988: Carlo Stella C; Cazzola M; Ganser A; Bergamaschi G; Meloni F; Pedrazzoli P; Bernasconi P; Invernizzi R; Hoelzer D; Ascari E
Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(1):55-9.
1987: Cazzola M; D'Amato G; Lobefalo G; Guillaro B; Sepe J; Assogna G; Pietroletti R; Lauria D
Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways.
Chest 1987;92(5):863-6.
1987: Marmo E; Filippelli W; Marrazzo R; Russo S; Cazzola M; Vacca C; Rossi F
Participation of GABAergic mechanisms in the hypotensive and bradycardic effects of clonidine: experimental study in conscious normotensive and hypertensive rats.
Neuropharmacology 1987;26(10):1525-8.
1987: Carlo-Stella C; Cazzola M; Gasner A; Barosi G; Dezza L; Meloni F; Pedrazzoli P; Hoelzer D; Ascari E
Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.
Blood 1987;70(4):1014-9.
1987: Cazzola M; Bergamaschi G; Huebers H A; Finch C A
Pathophysiological classification of acquired bone marrow failure based on quantitative assessment of erythroid function.
European journal of haematology 1987;38(5):426-32.
1987: Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco C M; Cassano E; Danova M; Ucci G; Castello A; Coci A
Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Blut 1987;54(3):153-63.
1986: Zappone E; Bellotti V; Cazzola M; Ceroni M; Meloni F; Pedrazzoli P; Perfetti V
Cerebrospinal fluid ferritin in human disease.
Haematologica 1986;71(2):103-7.
1983: Dezza L; Cazzola M; Bergamaschi G; Burgio V L; Stella C C; Fenoglio C; Ghizzi A; Nalli G; Sacchi F; Ascari E
Myelodysplastic syndrome with monosomy 7 in adulthood: a distinct preleukaemic disorder.
Haematologica 1983;68(6):723-35.

Sign-in to see more